| Aflatoxin B (B1 + B2) (μgg−1)s | R (%)t | Treatment efficiency (TE) |
---|
Non-aflatoxigenic r | (2:1) | (4:1) | (2:1) | (4:1) | (2:1) | (4:1) |
---|
CHv 1051 | 49a | 69a | 51.0 | 34.9 | 1.02a | 1.72b |
CHr 1701 | 44a | 72b | 56.4 | 32.1 | 1.13ab | 1.61b |
GWe 2274 | 46b | 79b | 54.5 | 25.5 | 1.09a | 1.26a |
CHp 1019 | 40a | 80b | 60.4 | 24.5 | 1.21c | 1.23a |
GKw 2471 | 48c | 59ab | 52.5 | 44.3 | 1.05a | 2.22c |
MRn 9932 | 46bc | 68a | 54.5 | 35.8 | 1.09a | 1.79bc |
MTd 0208 | 40a | 56c | 60.4 | 47.2 | 1.21c | 2.36c |
NRRL 21882 | 42a | 54c | 58.4 | 49.1 | 1.17ab | 2.46c |
ZMW 0127 | 101d | 106d | . . . | . . . | . . .d | . . .d |
- rNRRL 21882: Afla-Guard active ingredient. ZMW 0127 produces aflatoxins and it represents the positive control
- sAtoxigenic and toxigenic isolates were co-inoculated at 1 × 106 total conidia ml−1 in two ratios of concentrations: 100% toxigenic and 50% atoxigenic (2:1) and 80% toxigenic and 20% atoxigenic (4:1)
- tAflatoxin B reduction (%) = [1 – (total aflatoxin content in groundnut seed co-inoculated with both toxigenic and atoxigenic isolates of Aspergillus flavus/total aflatoxin content in groundnut seed inoculated with ZMW 0127)] × 100
- Mean values with the same superscript letter within a column are not significantly different @ 5% significance level